Amherst, NH, United States of America

Todd A Ballantyne

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 4.0

ph-index = 15

Forward Citations = 1,331(Granted Patents)


Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: The Innovative Mind of Todd A. Ballantyne: Pioneering Blood Treatment Technologies

Introduction: Todd A. Ballantyne, based in Amherst, NH, is a prolific inventor with an impressive portfolio of 25 patents. His work primarily focuses on advancements in blood treatment systems, particularly in the field of dialysis. His innovative approach and dedication to enhancing patient care have positioned him as a notable figure in medical technology.

Latest Patents: Todd's latest patents encompass groundbreaking developments in dialysis systems. These systems include new fluid flow circuits designed to improve blood and dialysate flow paths. Notably, they feature balancing, mixing, and directing circuits that allow for decoupled dialysate preparation, ensuring efficiency during patient dialysis. Moreover, Todd's designs include emergency features, such as a gas supply that helps manage dialysate flow and blood return to patients under critical conditions. His inventions also integrate advanced fluid handling devices like pumps, valves, and mixers, which can be actuated using an external control fluid, thereby enhancing the reliability of the dialysis processes.

Career Highlights: Throughout his career, Todd has contributed significantly to the development of innovative healthcare solutions. His tenure at notable companies, including Deka Products Limited Partnership and Acuity Imaging, LLC, provided him with a platform to refine his skills and implement his inventive concepts in real-world applications. Todd's work not only demonstrates his technical expertise but also his commitment to improving medical treatments through innovation.

Collaborations: Todd has collaborated with esteemed professionals such as Michael J. Wilt and Jason A. Demers. These partnerships have fostered the exchange of ideas, driving further advancements in the technology and methodologies associated with blood treatment systems.

Conclusion: Todd A. Ballantyne's contributions to dialysis technology are fundamental to the ongoing enhancements in patient care within the medical field. His 25 patents reflect a dedication to innovation and a deep understanding of the complexities involved in blood treatment systems. As he continues to push the boundaries of technology, Todd remains an influential figure in the realm of medical inventions, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…